Literature DB >> 12490689

Molecular signatures of breast cancer--predicting the future.

Anne Kallioniemi.   

Abstract

Entities:  

Mesh：

Year:  2002        PMID： 12490689     DOI： 10.1056/NEJMe020152

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  5 in total

Review 1.  Expression profiling of human breast cancers and gene regulation by progesterone receptors.

Authors:  Britta M Jacobsen; Jennifer K Richer; Carol A Sartorius; Kathryn B Horwitz
Journal:  J Mammary Gland Biol Neoplasia       Date:  2003-07       Impact factor: 2.673

2.  Do physicians tailor their recommendations for breast cancer risk reduction based on patient's risk?

Authors:  Jennifer S Haas; Celia P Kaplan; Steven E Gregorich; Eliseo J Pérez-Stable; Genevieve Des Jarlais
Journal:  J Gen Intern Med       Date:  2004-04       Impact factor: 5.128

3.  Automated quantitative assessment of HER-2/neu immunohistochemical expression in breast cancer.

Authors:  Hela Masmoudi; Stephen M Hewitt; Nicholas Petrick; Kyle J Myers; Marios A Gavrielides
Journal:  IEEE Trans Med Imaging       Date:  2009-01-19       Impact factor: 10.048

Review 4.  Genomic and proteomic approaches for studying human cancer: prospects for true patient-tailored therapy.

Authors:  Kristen M Carr; Kevin Rosenblatt; Emanuel F Petricoin; Lance A Liotta
Journal:  Hum Genomics       Date:  2004-01       Impact factor: 4.639

5.  MicroRNA-623 inhibits tumor progression and is a predictor of poor prognosis of breast cancer.

Authors:  Chunfeng Wang; Juan Wang; Jing Zhang; Yongxiang Li; Qinghui Sun; Feng Guo; Xiupeng An
Journal:  Oncol Lett       Date:  2020-10-29       Impact factor: 2.967
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.